SynthesisBMC infectious diseases2024

Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis.

Yishak Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.